Atm--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** reqs: Atm [RNAi]
    *** source: 14651848-Fig-6a
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** reqs: Atm [RNAi]
    *** source: 20932476-Fig-S2
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293<xNemo><xSumo1> in BMS
    *** reqs: Atm [RNAi]
    *** source: 14651848-Fig-6b

not Atr--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** does not req: Atr [RNAi]
    *** source: 14651848-Fig-6a

Erc1--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** reqs: Erc1 [RNAi]
    *** source: 16497931-Fig-5a
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: mEFs in BMS
    *** reqs: Erc1 [KO]
    *** source: 20932476-Fig-3e

not Chek1--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293<xNemo><xSumo1> in BMS
    *** does not req: Chek1 [RNAi]
    *** source: 14651848-Fig-6b

not Cyld--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** partially inhibited by: xCyld [addition]
    *** unaffected by: xCyld(mnr)"CIA" [addition]
    *** source: 20932476-Fig-5f

Nemo--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** reqs: xNemo [omission]
    *** source: 16497931-Fig-1a
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3 in BMS
    *** inhibited by: xNemo(1-394)"delC" [addition]
    *** source: 12138192-Fig-5a
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** inhibited by: Nemo(Q86N) [substitution]
    *** inhibited by: Nemo(Q86A) [substitution]
    *** source: 16497931-Fig-1f
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** inhibited by: xNemo(K277A/K309A) [substitution]
    *** source: 14651848-Fig-2e
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** inhibited by: xNemo(L329P) [substitution]
    *** source: 20932476-Fig-S5a
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** inhibited by: xNemo(S85A) [substitution]
    *** inhibited by: xNemo(F312A) [substitution]
    *** source: 20932476-Fig-S5b
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** inhibited by: xNemo(S85A) [substitution]
    *** inhibited by: xNemo(Y308A) [substitution]
    *** source: 20932476-Fig-S5c
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** inhibited by: xNemo(S85A) [substitution]
    *** source: 16497931-Fig-1b
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** inhibited by: xNemo(sumo/S85A) [substitution]
    *** source: 16497931-Fig-S3b
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** partially inhibited by: xNemo(K277A) [substitution]
    *** partially inhibited by: xNemo(K309A) [substitution]
    *** source: 14651848-Fig-2d
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** unaffected by: xNemo(S8A) [substitution]
    *** inhibited by: xNemo(S85A) [substitution]
    *** partially inhibited by: xNemo(S156A) [substitution]
    *** partially inhibited by: xNemo(S364A) [substitution]
    *** partially inhibited by: xNemo(S383A) [substitution]
    *** source: 16497931-Fig-S1c
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** unaffected by: xNemo(sumo) [substitution]
    *** source: 14651848-Fig-4d
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** reqs: Nemo [RNAi]
    *** source: 16497931-Fig-5a
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293<xNemo> in BMS
    *** unaffected by: xNemo(S85A) [substitution]
    *** source: 16497931-Fig-3b
  *** Nfkb[RE] oligo-binding[EMSA] is unchanged irt Etoposide (2 hr)
    *** cells: 70Z3<Nemo~null><xNemo(1-394)"delC"> in BMS
    *** source: 12138192-Fig-5a

not Ripk1--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** does not req: Ripk1 [RNAi]
    *** source: 16497931-Fig-5a

not Rsk1--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** does not req: Rsk1 [RNAi]
    *** source: 16497931-Fig-5a

Tab2--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** reqs: Tab2 [RNAi]
    *** source: 20932476-Fig-S1a

Tab3--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** reqs: Tab3 [RNAi]
    *** source: 20932476-Fig-S1a

Tak1--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** partially reqs: Tak1 [RNAi]
    *** source: 20932476-Fig-S2
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** reqs: Tak1 [RNAi]
    *** source: 20932476-Fig-1d

Traf2--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** reqs: Traf2 [RNAi]
    *** source: 20932476-Fig-S5d

Traf5--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** partially reqs: Traf5 [RNAi]
    *** source: 20932476-Fig-S5d

Ubc13--

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: HEK293 in BMS
    *** reqs: Ubc13 [RNAi]
    *** source: 20932476-Fig-5d


chemicals

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (1 hr)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** inhibited by: NBDpeptide [pretreatment]
    *** source: 14651848-Fig-4c

no extras

  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: CEM in BMS
    *** partially inhibited by: LMB [pretreatment]
    *** source: 14651848-Fig-7b
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (2 hr)
    *** cells: hPBTCs in BMS
    *** source: 16497931-Fig-2g
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (times)
    *** cells: 70Z3<Nemo~null><xNemo(sumo)> in BMS
    *** times: 0+ 30+ 60++ 120++ 180++ 240++ 480+ min
    *** source: 14651848-Fig-5c
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (times)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** times: 0 30+ 60++ 120++ 180+ 240+ 480 min
    *** source: 14651848-Fig-5c
  *** Nfkb[RE] oligo-binding[EMSA] is increased irt Etoposide (times)
    *** cells: 70Z3<Nemo~null><xNemo> in BMS
    *** times: 0+ 30+ 45+ 60++ 90++ 120++ min
    *** source: 14651848-Fig-5a

